About LipoScience (NASDAQ:LPDX)
LipoScience, Inc. is a vitro diagnostic company. The Company's diagnostic test, the nuclear magnetic resonance (NMR) LipoProfile test, directly measures the number of low density lipoprotein (LDL), particles in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. The Company's Vantera system is the Company's automated clinical analyzer. As of January 25, 2013, over eight million NMR LipoProfile tests were ordered. The Vantera system is its automated clinical analyzer. In August 2012, the Company received Food and Drug Administration (FDA) clearance to market the Vantera system commercially to laboratories.
Industry, Sector and Symbol
Industry Diagnostic & Testing Substances Manufacturers
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
LipoScience (NASDAQ:LPDX) Frequently Asked Questions
What is LipoScience's stock symbol?
LipoScience trades on the NASDAQ under the ticker symbol "LPDX."
How were LipoScience's earnings last quarter?
LipoScience Inc (NASDAQ:LPDX) posted its quarterly earnings results on Wednesday, November, 12th. The biotechnology company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.26) by $0.02. The biotechnology company earned $8.56 million during the quarter, compared to the consensus estimate of $8.80 million. During the same period last year, the business earned ($0.31) EPS. View LipoScience's Earnings History.
Who are some of LipoScience's key competitors?
Some companies that are related to LipoScience include Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Novartis (NVS), Pfizer (PFE), Roche (ROG), Merck & Co., Inc. (MRK), Amgen (AMGN), Novo Nordisk A/S (NVO), Sanofi (SNY), Gilead Sciences (GILD), Bristol-Myers Squibb (BMY), Abbott Laboratories (ABT), GlaxoSmithKline (GSK), Eli Lilly and (LLY), Sanofi (SAN), AstraZeneca (AZN), Bayer (BAYN) and Thermo Fisher Scientific (TMO).
How do I buy LipoScience stock?
Shares of LipoScience can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact LipoScience?
LipoScience's mailing address is 2500 Sumner Blvd, RALEIGH, NC 27616-3235, United States. The biotechnology company can be reached via phone at +1-919-2121999.
MarketBeat Community Rating for LipoScience (LPDX)MarketBeat's community ratings are surveys of what our community members think about LipoScience and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
LipoScience (NASDAQ:LPDX) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
LipoScience (NASDAQ:LPDX) Earnings History and Estimates Chart
LipoScience (NASDAQ LPDX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/12/2014||Q3 14||($0.26)||($0.28)||$8.80 million||$8.56 million||View||N/A|
|8/12/2014||Q2 2014||($0.24)||($0.27)||$8.90 million||$9.05 million||View||N/A|
|5/12/2014||Q1 14||($0.19)||($0.13)||$12.25 million||$12.01 million||View||N/A|
|3/10/2014||Q413||($0.24)||($0.17)||$12.71 million||$12.72 million||View||N/A|
LipoScience (NASDAQ:LPDX) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for LipoScience (NASDAQ:LPDX)
No dividend announcements for this company have been tracked by MarketBeat.com
LipoScience (NASDAQ LPDX) Insider Trading and Institutional Ownership History
LipoScience (NASDAQ LPDX) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|12/4/2013||Daniel Levangie||Director||Buy||10,000||$4.17||$41,700.00||1,122|| |
|12/4/2013||E. Duffy Mcdonald||VP||Sell||12,731||$4.07||$51,815.17||3,765|| |
|11/25/2013||James Hurley||Director||Buy||5,100||$3.91||$19,941.00||3,715|| |
|11/18/2013||Robert Greczyn, Jr.||CEO||Buy||10,000||$4.15||$41,500.00||9,091|| |
|1/30/2013||Buzz Benson||Director||Buy||50,000||$9.00||$450,000.00|| |
|1/30/2013||Three Arch Capital Lp||Major Shareholder||Buy||215,000||$9.00||$1,935,000.00|| |
LipoScience (NASDAQ LPDX) News Headlines
No headlines for this company have been tracked by MarketBeat.com
LipoScience (NASDAQ:LPDX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
LipoScience (NASDAQ:LPDX) Income Statement, Balance Sheet and Cash Flow Statement
LipoScience (NASDAQ LPDX) Stock Chart for Monday, January, 22, 2018